Trade Moderna Inc ^MRNA

Invesco S&P 500 Equal Weight (RSP) Sells $1.1 Million of Moderna on Monday

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Moderna (NASDAQ:MRNA) Shares Up 6.7% - What's Next?

Dow leads Wall Street higher, investors focus on healthcare stocks

Moderna (NASDAQ:MRNA) Sets New 1-Year High - Here's What Happened

Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%

Should Leadership Hire Require Action From Everest Medicines (SEHK:1952) Investors?

Healthcare Stocks To Research - October 20th - Markets Daily

Moderna (NASDAQ:MRNA) Stock Price Up 6.7% - What's Next? - Daily Political

Bank Pictet & Cie Europe AG Sells 6,591 Shares of Moderna, Inc. $MRNA - Daily Political

Moderna, Inc. $MRNA Shares Sold by BDF Gestion

Moderna, Inc. (NASDAQ:MRNA) Stock Has Consensus Target Price of $101.45

Moderna (NASDAQ:MRNA) Shares Climb 4.1% - What's Next?

Moderna (NASDAQ:MRNA) Shares Climb 4.1% - Should You Buy? - Stock Observer

Invesco S&P 500 Equal Weight (RSP) Sells Moderna and PTC on Thursday

Moderna, Inc. $MRNA Shares Purchased by TD Waterhouse Canada Inc.

Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer

Healthcare Stocks To Consider - October 15th - Markets Daily

Kintegral Advisory LLC Buys New Holdings in Moderna, Inc. $MRNA - Stock Observer

Moderna, Inc. $MRNA Shares Sold by V Square Quantitative Management LLC - Stock Observer

Healthcare Stocks To Consider - October 17th - Markets Daily

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

4,620 Shares in Moderna, Inc. $MRNA Purchased by St. Louis Financial Planners Asset Management LLC

Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA

Phase 3 Cancer Vaccine Success Could Change The Case For Moderna Stock

Moderna (NASDAQ:MRNA) Stock Price Down 7.8% After Insider Selling

Moderna (NASDAQ:MRNA) Stock: Insider Stephen Hoge Sells 39,224 Shares

Insider Selling: Moderna (NASDAQ:MRNA) President Sells 39,145 Shares of Company Stock

Insider Selling: Moderna (NASDAQ:MRNA) President Sells $8,640,084.40 in Stock - Stock Observer

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Moderna (NASDAQ:MRNA) Stock Falls 9.5% - Here's What Happened

Moderna stock sinks as Wall Street turns cautious following blistering rally

Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put

Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer

Moderna (NASDAQ:MRNA) Shares Climb 4.6% - Still a Buy? - Daily Political

15,000 Moderna, Inc. $MRNA Shares Sold by Quattro Financial Advisors LLC

NFSG Corp Purchases 5,162 Shares of Moderna, Inc. $MRNA - Markets Daily

Moderna, Inc. $MRNA Position Lifted by NFSG Corp - Stock Observer

Promising Biotech Stocks To Follow Today - October 13th - Stock Observer

'AI lowers the capital needed': India's drug discovery push faces test of human trials

Moderna (NASDAQ:MRNA) Shares Up 4.5% Following Analyst Upgrade

Moderna (NASDAQ:MRNA) Shares Climb 4.5% Following Analyst Upgrade

PFG Private Wealth Management LLC Makes New Investment in Moderna, Inc. $MRNA - Zolmax

Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher

Moderna Stock Is Soaring on Cancer Vaccine Buzz. Is It Too Late to Get In?

Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

PFG Private Wealth Management LLC Acquires New Shares in Moderna, Inc. $MRNA - Daily Political

Healthcare Stocks To Consider - October 15th - Daily Political

Strategy Asset Managers LLC Purchases 13,021 Shares of Moderna, Inc. $MRNA

Analysts' Recent Ratings Updates for Moderna (MRNA) - Stock Observer

Moderna designs bispecific antibodies against SARS-CoV-2 variants | BioWorld

Moderna (NASDAQ:MRNA) Stock Price Up 4.6% - Time to Buy?

Merck CEO: Cancer vaccine manufacturing time could shrink

Top Healthcare Stocks To Research - October 14th - Stock Observer

Top Biotech Stocks To Research - October 14th - Stock Observer

Moderna (NASDAQ:MRNA) Hits New 52-Week High on Analyst Upgrade - Markets Daily

AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyan

Promising Healthcare Stocks To Keep An Eye On - October 11th - Stock Observer

Healthcare Stocks To Watch Today - October 12th - Stock Observer

Moderna, Inc. $MRNA Shares Sold by Contravisory Investment Management Inc.

Sivik Global Healthcare LLC Makes New Investment in Moderna, Inc. $MRNA

Moderna co-founder Noubar Afeyan calls for urgent regulation of AI agents

'Pharma Bro' Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks | Morningstar

Moderna (NASDAQ:MRNA) Shares Up 1.2% - Here's Why - Daily Political

Moderna Founder Calls for Urgent Regulation of AI Agents

Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?

Promising Healthcare Stocks To Keep An Eye On - October 11th - Zolmax

Biotech Stocks To Watch Today - October 11th - Daily Political

Health Canada reviewing new mRNA flu vaccine that could prevent more hospitalisations

Moderna stock surges more than 600% in 2026

Merck (MRK) Could Be 7% Below Fair Value On Phase III Cancer Vaccine Results

Healthcare Stocks To Watch Today - October 12th - Markets Daily

Moderna (NASDAQ:MRNA) Reaches New 12-Month High - Still a Buy?

These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?

Palantir CTO Shyam Sankar says researchers have started smoking, believing AI will cure cancer

Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?

Moderna (MRNA) Is Up 18.4% After Cancer Vaccine Milestone And Nasdaq-100 Return Has The Bull Case Changed?

Moderna (MRNA) Stock Looks Expensive Following Its 7x One Year Run

Moderna (MRNA) Stock Sees Modest Fair Value Lift After Cancer Vaccine Analyst Revisions

Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar

mRNA Vaccine Hires Could Be A Game Changer For Everest Medicines (SEHK:1952)

Promising Value Stocks Worth Watching - October 10th - Zolmax

Promising Healthcare Stocks To Follow Today - October 10th - Zolmax

Top Biotech Stocks To Watch Now - October 10th - Markets Daily

Moderna (NASDAQ:MRNA) Price Target Raised to $95.00 - Zolmax

MRNA: Melanoma Success Changed The Story, The Stock Still Prices In Too Much

Moderna (MRNA) Hits New 52-Week High Amid Cancer Vaccine Buzz an

Weekly Market Update: Stocks Gain 1.03% as Utilities Rise, Industrials Fall | Morningstar

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High - Here's Why

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Moderna, Inc. $MRNA Shares Sold by Douglas Lane & Associates LLC

Moderna stock jumps on planned national cancer vaccine effort

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up

Rep. Maria Elvira Salazar Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)

RBC Capital Remains a Hold on Moderna (MRNA)

Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?